These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 12485219

  • 1. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J, Phillips A, Lawes C, Rodgers M, Windsor J, McCall J.
    ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
    [Abstract] [Full Text] [Related]

  • 2. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.
    Henson DE, Schwartz AM, Nsouli H, Albores-Saavedra J.
    Arch Pathol Lab Med; 2009 Jan; 133(1):67-71. PubMed ID: 19123739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M, Wee A, Raju GC.
    Cancer; 1994 Sep 01; 74(5):1542-5. PubMed ID: 7520348
    [Abstract] [Full Text] [Related]

  • 5. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar 01; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endoscopic ultrasonography assessment in preoperative staging for carcinoma of ampulla of Vater and extrahepatic bile duct.
    Zhang Q, Nian W, Zhang L, Liang J.
    Chin Med J (Engl); 1996 Aug 01; 109(8):622-5. PubMed ID: 9206064
    [Abstract] [Full Text] [Related]

  • 8. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS, Pirdas A.
    Pathology; 1995 Apr 01; 27(2):117-20. PubMed ID: 7567135
    [Abstract] [Full Text] [Related]

  • 9. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.
    Castro FA, Koshiol J, Hsing AW, Devesa SS.
    Int J Cancer; 2013 Oct 01; 133(7):1664-71. PubMed ID: 23504585
    [Abstract] [Full Text] [Related]

  • 10. Incidence and mortality trends for biliary tract cancers in Austria.
    Pinter M, Hucke F, Zielonke N, Waldhör T, Trauner M, Peck-Radosavljevic M, Sieghart W.
    Liver Int; 2014 Aug 01; 34(7):1102-8. PubMed ID: 24119058
    [Abstract] [Full Text] [Related]

  • 11. Incidence of cancer of the pancreas, extrahepatic bile duct and ampulla of Vater in the United States, before and after the introduction of laparoscopic cholecystectomy.
    Urbach DR, Swanstrom LL, Khajanchee YS, Hansen PD.
    Am J Surg; 2001 Jun 01; 181(6):526-8. PubMed ID: 11513778
    [Abstract] [Full Text] [Related]

  • 12. Rising incidence of biliary tract cancers in Shanghai, China.
    Hsing AW, Gao YT, Devesa SS, Jin F, Fraumeni JF.
    Int J Cancer; 1998 Jan 30; 75(3):368-70. PubMed ID: 9455795
    [Abstract] [Full Text] [Related]

  • 13. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS, Pirdas-Zivcic A.
    Pathology; 1994 Oct 30; 26(4):448-52. PubMed ID: 7892048
    [Abstract] [Full Text] [Related]

  • 14. Hepatobiliary cancers, version 2.2014.
    Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.
    J Natl Compr Canc Netw; 2014 Aug 30; 12(8):1152-82. PubMed ID: 25099447
    [Abstract] [Full Text] [Related]

  • 15. Trends in biliary tract cancer.
    Nectoux J, Coleman MP.
    Rev Epidemiol Sante Publique; 1993 Aug 30; 41(2):113-22. PubMed ID: 8493389
    [Abstract] [Full Text] [Related]

  • 16. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A.
    J Pathol; 2005 Jul 30; 206(3):356-65. PubMed ID: 15892172
    [Abstract] [Full Text] [Related]

  • 17. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A, Wittekind C.
    Internist (Berl); 2004 Jan 30; 45(1):33-41. PubMed ID: 14735242
    [Abstract] [Full Text] [Related]

  • 18. Descriptive epidemiology of bile duct carcinoma in Osaka.
    Ikeda A, Miyashiro I, Nakayama T, Ioka A, Tabuchi T, Ito Y, Tsukuma H.
    Jpn J Clin Oncol; 2013 Nov 30; 43(11):1150-5. PubMed ID: 24014885
    [Abstract] [Full Text] [Related]

  • 19. Gallbladder carcinoma: a New Zealand centre's 10-year experience with presentation, ethnic diversity and survival rate.
    Lilic N, Addison B, Hammodat H.
    ANZ J Surg; 2015 Apr 30; 85(4):260-3. PubMed ID: 24438645
    [Abstract] [Full Text] [Related]

  • 20. Assessment of endoscopic aspiration cytology and endoscopic retrograde cholangio-pancreatography in patients with cancer of the hepato-biliary tract. Part II.
    Harada H, Sasaki T, Yamamoto N, Tanaka J, Tomiyama Y.
    Gastroenterol Jpn; 1977 Apr 30; 12(1):59-64. PubMed ID: 863180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.